Review





Similar Products

cdp 323  (Biogen Inc)
90
Biogen Inc cdp 323
Main industry-sponsored studies for oral NME currently in development for multiple sclerosis
Cdp 323, supplied by Biogen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cdp-323/cdp323/pmc03011221-18-0-10
Average 90 stars, based on 1 article reviews
cdp 323 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
cdp-323 (zaurategrast)  (Adooq Bioscience LLC)
90
Adooq Bioscience LLC cdp-323 (zaurategrast)
Main industry-sponsored studies for oral NME currently in development for multiple sclerosis
Cdp 323 (Zaurategrast), supplied by Adooq Bioscience LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cdp-323/cdp+323++zaurategrast+/pmc04611147-94-0-5
Average 90 stars, based on 1 article reviews
cdp-323 (zaurategrast) - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
dual 4 inhibitor cdp-323  (Biogen Inc)
90
Biogen Inc dual 4 inhibitor cdp-323
Main industry-sponsored studies for oral NME currently in development for multiple sclerosis
Dual 4 Inhibitor Cdp 323, supplied by Biogen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cdp-323/cdp323/10__2174_slash_157339512800099666-384-13-0
Average 90 stars, based on 1 article reviews
dual 4 inhibitor cdp-323 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
cdp-323  (Biogen Inc)
90
Biogen Inc cdp-323
Main industry-sponsored studies for oral NME currently in development for multiple sclerosis
Cdp 323, supplied by Biogen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cdp-323/cdp323/pm17631252-126-14-11
Average 90 stars, based on 1 article reviews
cdp-323 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
cdp-323  (Celltech Inc)
90
Celltech Inc cdp-323
Main industry-sponsored studies for oral NME currently in development for multiple sclerosis
Cdp 323, supplied by Celltech Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cdp-323/cdp+323/pm17631252-119-1-14
Average 90 stars, based on 1 article reviews
cdp-323 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
spirocyclic ethyl ester derivative 14 cdp-323  (Celltech Inc)
90
Celltech Inc spirocyclic ethyl ester derivative 14 cdp-323
Main industry-sponsored studies for oral NME currently in development for multiple sclerosis
Spirocyclic Ethyl Ester Derivative 14 Cdp 323, supplied by Celltech Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cdp-323/cdp+323/10__1517_slash_13543776__18__8__841-189-1-21
Average 90 stars, based on 1 article reviews
spirocyclic ethyl ester derivative 14 cdp-323 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
compound cdp-323  (Celltech Inc)
90
Celltech Inc compound cdp-323
Main industry-sponsored studies for oral NME currently in development for multiple sclerosis
Compound Cdp 323, supplied by Celltech Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cdp-323/cdp+323/pm16989599-203-1-0
Average 90 stars, based on 1 article reviews
compound cdp-323 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


Main industry-sponsored studies for oral NME currently in development for multiple sclerosis

Journal: mAbs

Article Title: Monoclonal antibody therapy in multiple sclerosis

doi: 10.4161/mabs.2.6.13270

Figure Lengend Snippet: Main industry-sponsored studies for oral NME currently in development for multiple sclerosis

Article Snippet: CDP 323 , Phase 2 terminated , {"type":"clinical-trial","attrs":{"text":"NCT00484536","term_id":"NCT00484536"}} NCT00484536 , Biogen Idec UCB , p.o. , Integrin alpha4 antagonist , Placebo , RMS.

Techniques: